World Archaeology: Excavating a Punic-Roman port city on Sardinia
World Archaeology spotlights a UC-based excavation at Tharros by UC archaeologist Steven Ellis
An archaeological project in the Punic-Roman city of Tharros on the western shores of Sardinia led by Steven Ellis, an associate professor of classics at the University of Cincinnati, is highlighted in the current edition of World Archaeology magazine. The project, based out of UC’s Department of Classics, involves excavations targeting the underexplored city’s residential and retail quarters in search of what the once bustling port town can reveal about the socio-economic fabric of Punic and Roman life at the time. The team is especially interested in identifying the town’s diet and urban consumption, social stratigraphy and the motivations behind urban investment, as well as civic infrastructure.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.